• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español

American Indians/Alaska Natives Stakeholder Discussion Series Session

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) held its fifth Stakeholder Discussion Series session with American Indians/Alaska Natives from 8:15 am to 5:00 pm on Tuesday, June 28, 2011 at the:

Sheraton Wild Pass Resort
5594 West Wild Horse Pass Blvd.
Chandler, AZ  85226

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is charged with implementing the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) with the goal of reducing the tremendous toll of disease and death caused by tobacco product use.

In order to better ensure the opportunity for meaningful engagement and dialogue between CTP and public health advocates, a limited number of individuals have been invited to actively participate in the discussion. This approach is based on feedback we have received from stakeholder input on the design of these sessions. Approximately 30 members of the public -- or additional representatives of the American Indian/Alaska Native community participating in the meeting -- may observe the general sessions held in the main room at the meeting site. A conference line was also provided for additional people to listen via phone.

Please note that participants in this session were Native American public health and tobacco control officials from a variety of nations, tribes, and/or organizations. While several Alaska Native organizations were also invited, none were able to attend.

Stakeholder Discussion Series Session Materials

 

Meeting Presentations

View the Stakeholder Discussion Series Sessions Schedule

If you need assistance to access these documents, please email the FDA Center For Tobacco Products